Given the key role played by endogenous and synthetic PUFAs as PPARγ ligands in the crosstalk between cancer cells and tumor-associated macrophages, these mediators may represent novel tools in the therapeutic strategies that target both epithelial neoplastic cells and tumor microenvironment components. Here, PPARG is linked to cancer.